Dissociative Experiences Scale (DES-II): Scores, Uses, and Limitations
Author: Angela Bogdanova · Published: October 9, 2026 · Editorial Policy
Research cluster: Dissociation & Dissociative Disorders · Written by Artificial Sapiens
The Dissociative Experiences Scale–II (DES-II) is a 28-item self-report questionnaire that measures how frequently people experience phenomena such as absorption, depersonalization, derealization, and gaps in awareness or memory. Each response runs from 0% to 100%, and the total score is the average across all 28 items. The scale can support screening and research assessment, but it cannot diagnose dissociative identity disorder (DID) or another condition. Original development research and a 2025 systematic review establish the measure's scientific background.
What is the DES-II?
Eve M. Bernstein and Frank W. Putnam developed the Dissociative Experiences Scale in 1986. The DES-II preserves its 28-item scope while using response choices in ten-percentage-point increments, rather than the original analog response lines. It asks about the frequency of reported experiences, not their cause, clinical severity, or truth of remembered historical events. Bernstein and Putnam, 1986.
How are DES-II scores calculated?
Add the percentage responses to all 28 items and divide by 28. For example, if the responses sum to 560, the total is 560 ÷ 28 = 20. Every item has equal weight and no items are reverse-scored. A score of 20 is an average questionnaire response, not proof that the person is dissociated during exactly 20 percent of waking life. The complete instrument is needed for its conventional total; partial online quizzes are not automatically interchangeable with the standardized DES-II.
Why does a DES-II score not establish a diagnosis?
Two respondents may have the same total but very different patterns of experience. One may endorse everyday absorption; another may report clinically concerning loss of time. Their clinical needs differ, and other medical or psychiatric explanations may be relevant. The DES-II is a screening and descriptive tool, while diagnosis requires assessment of clinical criteria, history, impairment and differential explanations. See WHO ICD-11 clinical diagnostic requirements. For a related clinical perspective, see How Are Dissociative Disorders Diagnosed? Interviews and Differential Diagnosis.
What does the DES-II actually measure?
The instrument asks people to estimate how often experiences occur across 28 descriptions. Some items concern absorption: becoming so involved in a book, television program, or activity that surroundings fade from attention; reaching a familiar destination without clearly remembering the journey; or failing to register parts of ordinary conversations. Such phenomena exist on a continuum with familiar attentional experiences. The instrument also addresses more unusual disruptions in memory, self-experience, or perception. Endorsing one type does not mean endorsing the others. Different item patterns can generate the same total score, so the clinical question is always which experiences are present, when they occur, and how they affect functioning.
Absorption, depersonalization, derealization, and amnesia
Absorption involves focused attention or immersion; its presence alone does not imply illness. Depersonalization describes feeling detached from one's thoughts, body, feelings, or actions; derealization concerns one's surroundings seeming strange, distant, dreamlike, or unreal. People often maintain awareness that the perception is subjective. Amnesia-related experiences concern unexpected failures to recall personal behavior, conversations, or periods of time. The degree to which such events exceed normal forgetting, sleep-related effects, distraction, or other medical causes must be established by assessment. The WHO ICD-11 clinical requirements specify diagnostic distinctions; the DES-II does not map any particular item directly onto a diagnosis.
DES, DES-II, and timing of the experiences
The original DES used 28 visual-analog responses; DES-II is the widely used revision with response choices at 0, 10, 20, and so on to 100 percent. It measures estimated frequency of experiences across ordinary life rather than documenting the observed duration of a single episode. The standard instructions ask respondents to consider experiences when not under the influence of alcohol or drugs. Responses remain estimates, vulnerable to recall and interpretation. A DES-II score is a description of what someone reports, not an instrument for determining how many minutes they were objectively detached. Bernstein and Putnam's original validation established the broad response concept.
Step-by-step scoring and worked examples
The scoring rule is DES-II total = (sum of 28 percentage responses) / 28. Suppose all 28 items together total 280 percentage points; the mean is 10. If they total 840, the mean is 30. A single item scored at 100 contributes 100/28, or about 3.57 points, to the overall total. There are no reverse-keyed items in customary DES-II mean scoring, and the questions are not assigned different diagnostic weights. A full set of answers is required for the standard 28-item computation.
Why equal totals can conceal very different concerns
Consider two hypothetical respondents whose summed item scores both equal 560. The first scores highly on several absorption items and reports no clinically important periods of missing time. The second gives lower absorption responses but strongly endorses a handful of memory-continuity and detachment experiences that affect relationships or safety. Each has a mean of 20. The numerical similarity should never be mistaken for clinical equivalence. Item-level discussion, history, symptom duration, distress, impairment, and alternative explanations matter at least as much as the total.
Missing responses, altered questionnaires, and rounding
A partial set of responses is not a standard complete DES-II score. Research protocols may specify their own rules for handling missing values, but an online tool should not silently manufacture answers or present an undocumented prorated score as fully equivalent to the validated 28-item measure. Similarly, a quiz that changes wording, reduces the item count, changes response options, or adds its own categories is not automatically the same instrument. When a study or service uses a numerical threshold, the underlying average and its rounding rule should be handled as the protocol specifies. A raw average of 29.6 should not acquire diagnostic significance because a website rounds it to 30.
DES-II score interpretation: low, intermediate, and elevated values
The DES-II score ranges from 0 to 100; a higher value indicates a higher average self-reported frequency across the 28 item descriptions. There is no universally accepted set of score bands that separates the population into normal, mild, moderate, severe, and diagnostic categories. Published screening thresholds were chosen to answer particular questions, in particular groups, against particular diagnostic comparisons. A value on the scale needs to be interpreted alongside item responses and clinical context rather than through a generic severity chart. The 1993 multicenter study and 1991 outpatient comparison demonstrate how thresholds change depending on the screening purpose.
Below 10: low average endorsement
A score below 10 suggests that the respondent reports relatively few of the listed experiences on average. That can be reassuring when the person has no other significant concerns, but it cannot rule out an intermittent problem that the questions capture poorly. People who have substantial unexplained memory gaps, severe feelings of unreality, unusual episodes of lost awareness, or other impairing symptoms may require assessment even when they score below a screening threshold. Everyday daydreaming or absorption can also occur without any diagnosable disorder.
Scores around 10–20
These scores describe an average degree of reported experience, not a defined clinical syndrome. Researchers have explored lower thresholds, including 15–20, to identify a wider group who may merit follow-up for a broad range of dissociative conditions. In a small early outpatient study, lower cutoffs were useful for sensitivity; raising the threshold risked missing some cases. This finding does not turn a score of 15 or 20 into a diagnosis. The statistical performance came from that study's selected population and clinical reference assessment. Steinberg, Rounsaville, and Cicchetti, 1991.
Scores around 20–30
Scores in this range reflect more frequent endorsements overall, but they may result from high absorption, frequent detachment, memory concerns, or combinations of experiences. A score of 24, for example, is neither evidence that DID is present nor evidence that the person has experienced particular childhood events. The clinical importance of a repeated distressing memory gap may be greater than that of several common absorption experiences, regardless of where the overall mean falls. The cross-diagnostic meta-analysis by Lyssenko and colleagues found DES elevations in multiple psychiatric populations, reinforcing this caution.
A score of 30 or higher
The cutoff of 30 is frequently quoted because the DES was evaluated as a screen for what investigators then called multiple personality disorder, now termed DID. In the 1993 multicenter investigation, analyses reported approximately 76% sensitivity and 85% specificity in an evaluated sample; using the study's prevalence assumptions, its positive predictive value was about 17%. This means that a positive score was often a false positive for that specific diagnosis. These historical estimates must not be presented as exact probabilities for contemporary readers, different settings, or current DSM-5-TR diagnoses. They illustrate the difference between selecting people for more assessment and proving that a condition is present. Carlson et al., 1993.
Scores of 40, 50, or above
A very high score signals frequent endorsement across many items or extremely high responses to a smaller set. It can strengthen the case for a careful assessment when experiences are unexplained or impairing. There is no evidence-based universal number at which the DES-II alone determines identity alteration, a count of identity states, a particular trauma history, or a definitive dissociative disorder. Neither does it measure the intensity of biological disease on a 0-to-100 medical severity scale. The history behind the score remains essential.
Screening accuracy: sensitivity, specificity, and base rates
Sensitivity is the proportion of people with the target disorder whose screen is positive at a selected threshold. Specificity is the proportion of people without that disorder whose screen is negative. Positive predictive value is the proportion of positive screens that correctly identify the condition in the population being assessed. The last quantity depends heavily on the population's prevalence: a disorder that is uncommon in a broad general sample produces more false-positive screens than it would in a selected specialist clinic, even when sensitivity and specificity are held constant. The 1993 multicenter DES study explicitly illustrates why diagnostic conclusions cannot be deduced from a 30-point screen.
Different thresholds also change the tradeoff between missing patients who might benefit from assessment and evaluating people without the targeted disorder. Raising a cutoff can increase specificity at the cost of sensitivity; lowering it can identify more potentially relevant symptoms while generating more follow-up evaluations. The useful cutoff therefore depends on what condition is being screened for, the population, how costly a missed case would be, and what clinical assessment follows. There is no cutoff that turns self-report responses directly into a DSM-5-TR or ICD-11 diagnostic determination.
How strong is the science behind the DES-II?
Original validation and historical screening research
The original Bernstein and Putnam development paper provided evidence that a 28-item total could reliably quantify a range of self-reported dissociative experiences in the study's populations. Subsequent work evaluated test–retest consistency, internal consistency, group differences, and screening performance. These findings established an important assessment tool. Their samples, diagnostic conventions, and research methods nonetheless belong to particular historical contexts. Multiple personality disorder was an earlier name for DID, but modern clinical standards should not be retroactively treated as identical to every criterion used in 1980s and 1990s investigations.
The cross-diagnostic meta-analysis
In 2018, Lyssenko and colleagues analyzed 216 studies comprising 15,219 people across 19 diagnostic groups. Higher mean DES scores were seen in dissociative-disorder samples, but considerable elevation also occurred in PTSD, borderline personality disorder, and other clinical populations. These are group-level statistical patterns, not individual diagnostic bands. The finding supports taking dissociative phenomena seriously across several conditions while rejecting the idea that a high DES score identifies only DID. Group averages should not be converted into a diagnostic probability for a single reader.
The 2025 COSMIN systematic review
A registered systematic review led by Wainipitapong and colleagues searched MEDLINE, Embase, and PsycINFO and included 170 eligible studies of 44 dissociation measures and 14 adapted versions. It evaluated content, structural and cross-cultural validity, reliability, internal consistency, and measurement error under the COSMIN framework. The DES was among the best-supported measures of trait dissociation; the Adolescent DES, Peritraumatic Dissociative Experiences Questionnaire, Somatoform Dissociation Questionnaire–20, and Cambridge Depersonalisation Scale were better suited to other particular measurement domains. The review concluded that none of the measures fulfilled all demanding psychometric and methodological criteria. This is a meaningful qualification: a comparatively strong questionnaire may still have important gaps in reliability and content-validity research.
The authors also distinguished trait and state measures, developmental populations, and specific dissociative phenomena. Their conclusion does not mean that every DES-II score is invalid, nor does a favorable reliability coefficient turn a screen into a diagnosis. Psychometric quality is multidimensional. Internal consistency examines relations among items; test–retest reliability examines stability when change is not expected; measurement error describes uncertainty; and validity concerns whether particular interpretations are supported. Clinicians need to consider which question they actually want the questionnaire to answer.
The 2026 umbrella review: a multidimensional construct
A 2026 umbrella review by Garofalo and colleagues synthesized prior systematic reviews and meta-analyses on how dissociation is defined and measured. Across the reviews, researchers frequently described dissociation as multidimensional but often analyzed only questionnaire total scores. There was also inconsistency between categorical theories and the continuous measurements used in studies, with limited testing of cross-population comparability. This does not erase the value of the DES-II average; it cautions against assuming that one number settles which process or symptom combination a person has. Absorption, detachment, and compartmentalization may call for different clinical questions.
Are DES-II subscales diagnostic?
Researchers have investigated symptom clusters commonly associated with absorption, depersonalization and derealization, and amnesia. Different analytic methods and samples have produced different factor structures. A clinician may review patterns of item endorsement to understand what a person means by dissociation. The resulting clusters are not separate DSM-5-TR diagnoses and do not have universally validated cutoffs that diagnose their namesakes. The 2026 synthesis of assessment research shows why assuming identical factor structures across cultures and clinical groups is premature. Context and the actual experience should take precedence over an automatically generated profile.
DES-II versus DES-T
DES-II is the standard 28-item measure. DES-T is a subset of eight selected DES items that researchers used in work on experiences considered more characteristic of pathological dissociation. It is associated with taxometric attempts to identify distinctive patterns or latent categories. The existence of the eight-item subset does not convert its total into a diagnostic interview, establish the presence of a separate disease entity, or make its results interchangeable with the full DES-II mean. Websites should identify which score they are presenting. Related population-based taxometric research by Waller and Ross provides the research background.
How DES-II differs from SCID-D, MID, and other measures
SCID-D: structured diagnostic interviewing
The Structured Clinical Interview for Dissociative Disorders is clinician-administered and systematically explores distinct symptom domains, course, and diagnostic implications. It has a fundamentally different task from the DES-II: the screen indicates areas to investigate, while the structured interview contributes to differential diagnostic assessment. A meta-analysis of SCID-D studies reported evidence of differentiation between dissociative and comparison clinical groups. Its findings still depend on participant selection, reference conditions, interviewer expertise, and the quality of included studies. An interview also forms part of a wider clinical process when medical explanations may be relevant.
MID and targeted symptom instruments
The Multidimensional Inventory of Dissociation is a longer self-report questionnaire designed to profile a larger number of dissociative manifestations. Longer item coverage may provide clinically useful detail, but self-report length does not convert an instrument into independent diagnostic proof. The Cambridge Depersonalisation Scale focuses on depersonalization-related experiences; the Peritraumatic Dissociative Experiences Questionnaire addresses phenomena close in time to a potentially traumatic event. Their time windows and measured constructs differ from those of the DES-II. Researchers and clinicians should choose instruments on the basis of the target construct, intended population, psychometric evidence, and clinical purpose. Wainipitapong et al., 2025.
Age-appropriate scales
The standard adult DES-II should not be assumed appropriate for children and adolescents merely because its language appears simple. Developmental stage, imaginative play, communication, memory, and school context affect the interpretation of experiences. The Adolescent Dissociative Experiences Scale (A-DES) has a distinct evidence base; in the 2025 COSMIN review its adolescent measurement evidence received particularly favorable assessment. Child assessment can also involve parent or caregiver reports and specialist interviews. A youth screening score is not a diagnosis, and it should not be substituted for developmental and medical evaluation. Measurement systematic review.
What can raise or complicate a DES-II score?
Ordinary absorption, attention, memory, and sleep
Daydreaming, absorption in reading, automatic actions on a familiar route, and everyday lapses in attention are widely reported experiences. They can contribute to a questionnaire score without implying a dissociative disorder. Fragmented sleep, fatigue, stress, and distraction may affect how people describe awareness and recall. The clinical assessment asks whether events are unusual in degree or kind, recurrent, distressing, associated with a meaningful discontinuity in personal memory or agency, or accompanied by safety consequences. The presence of a common phenomenon on the DES-II does not make it pathological; an apparently familiar description can nevertheless merit careful follow-up when contextual details are concerning.
Panic, anxiety, PTSD, and personality disorders
Panic attacks and intense anxiety can involve depersonalization and derealization. PTSD can involve dissociative symptoms, including a recognized dissociative subtype within the PTSD diagnostic framework. People with borderline personality disorder and other psychiatric conditions may also report elevated dissociation. A DES-II total cannot decide which diagnosis accounts for the experiences, whether multiple conditions coexist, or whether an anxiety-focused or trauma-focused intervention is suitable. The 2018 DES meta-analysis demonstrates significant cross-diagnostic overlap. PTSD-centered diagnostic guidance and treatment remain owned by the trauma/PTSD field; a DES-II score only prompts questions that may lead there.
Psychosis, unusual perceptual experiences, and reality testing
A person who describes the world as unreal may recognize that the experience is a disturbing sensation rather than a literal transformation of the environment. Assessment of psychosis includes the nature of beliefs, hallucinations, thought organization, reality testing, functional changes, and relevant medical or substance factors. Some individuals can experience both dissociative and psychotic symptoms, so the presence of one kind cannot automatically rule out the other. A questionnaire score cannot distinguish them with sufficient certainty. Clinicians should explore the exact phenomenology without assuming that every sense of unreality is a hallucination or that unusual voices prove DID.
ADHD, ordinary forgetting, and dissociative memory gaps
Difficulties following a conversation, losing track of a task, or forgetting a recent action can have many explanations, including inattention, exhaustion, sleep disorders, anxiety, and other medical factors. ADHD is assessed through a characteristic developmental and functional pattern across settings, not inferred from a dissociation questionnaire. A clinically important amnesia presentation requires a history of unexpected memory loss exceeding ordinary forgetting, along with evaluation of possible alternative causes. The DES-II can identify areas of uncertainty but does not establish which mechanism is operating.
Medication, substance exposure, seizure-like episodes, and neurological illness
Medication effects, intoxicants, withdrawal, sleep-related states, seizures, head injuries, neurological disorders, and other physical illnesses may resemble some phenomena covered by dissociation measures. The standard questionnaire asks about non-intoxicated experiences, yet a self-report score cannot perform a neurological examination or determine whether episodes of lost awareness are seizures. Where there is new severe confusion, loss of consciousness, suspected seizure, new focal neurological symptoms, or recent serious head injury, appropriate urgent medical evaluation takes precedence over an online dissociation screen. Functional neurological symptoms and dissociative seizures have their own specialist diagnostic pathways; a DES-II result does not diagnose either.
Culture, language, and question interpretation
How people understand terms such as 'unreal,' 'automatic,' 'lost time,' or 'not myself' can vary across languages, communities, clinical contexts, and individual experiences. The original psychometric findings cannot simply be assumed to transfer to every adapted or translated questionnaire. Cultural and religiously framed trance or absorption practices may be voluntary and socially sanctioned; clinical assessment considers control, distress, impairment, and the surrounding cultural context. The 2026 umbrella review identified limited attention to cross-population comparability in dissociation measurement, an important qualification for international online screening.
Can DES-II diagnose dissociative identity disorder or another dissociative disorder?
No. Dissociative identity disorder, dissociative amnesia, depersonalization-derealization disorder, other specified dissociative disorder (OSDD), and related ICD-11 entities require clinical judgments tied to each diagnostic framework. DID involves distinctive identity discontinuity and associated symptoms and impairments; depersonalization-derealization disorder centers on persistent or recurrent detachment symptoms under the relevant criteria; dissociative amnesia concerns clinically significant autobiographical memory disturbance. A DES-II total has no validated one-to-one conversion into any of those diagnoses. DSM-5-TR and WHO ICD-11 classify overlapping clinical presentations in partly different ways, including distinct ICD-11 categories such as partial DID. This reflects differences between classification systems, not errors to be corrected by a screening number. Consult the WHO ICD-11 diagnostic requirements.
The instrument cannot reveal the number of identity states, establish which autobiographical claims are accurate, confirm a trauma history, or decide whether a person's reported internal experiences conform to a particular explanatory theory. Elevated screening results can reflect many symptom combinations; diagnostic interviews investigate their form, course, frequency, functional consequences, and possible psychiatric and medical alternatives. It is important to preserve the reality of distress without forcing that distress into a specific diagnosis on the basis of a single numeric score.
DES-II, trauma, memories, and suggestibility
Trauma exposure and dissociative experiences are associated in substantial research literatures, but associations do not establish the cause of any particular person's symptoms. The DES-II is not a test for childhood abuse, repression, recovered memory, or trauma-related biological changes. It asks respondents about experiences, not independently corroborated events. Even a very high mean cannot date an event or reconstruct its details. The evaluation of autobiographical memories, especially memories emerging during therapy, should be careful about suggestive questioning and the limits of recall. Clinical care can take distress seriously without treating new recollections as automatic historical confirmation.
Scientific debate about the mechanisms, conceptualization, and origins of dissociation and DID has involved different models of trauma-related processes, sociocognitive influences, memory, and suggestibility. A questionnaire score cannot resolve those competing accounts. The important assessment principle is to use nonleading questions, evaluate evidence proportionately, and avoid presuming causes before the clinical history has been explored. Cross-diagnostic patterns and measurement reviews support interpreting dissociative experiences within a wider context rather than converting one instrument into a causal test.
When should a person seek assessment after a DES-II result?
A qualified mental health professional can help when experiences are recurring, frightening, confusing, difficult to control, or interfering with school, work, relationships, or everyday safety. Unexpected and significant memory gaps, repeated feelings that the self or surroundings are unreal, episodes of lost time, or behavior others report that the person cannot recall are all reasons to discuss concerns irrespective of the numerical score. If the symptoms are new, severe, or associated with medical warning signs, primary medical or emergency assessment may be appropriate. A low DES-II score should not prevent someone from seeking help; a high one should not force them to adopt a diagnosis.
What happens in a clinical follow-up?
A clinician may ask for examples of experiences, age of onset, duration, precipitating contexts, sleep and substance history, relevant medication effects, functional impact, past psychiatric symptoms, and medical or neurological problems. The clinician may discuss a structured interview such as SCID-D or another measurement tool when indicated. The process distinguishes a single episode, a broader symptom pattern, screening concern, provisional diagnostic impression, and confirmed diagnosis. SCID-D meta-analytic research and WHO diagnostic guidance supply evidence for structured, context-sensitive assessment.
How to prepare for the appointment
It is useful to bring the specific item responses if available, a brief timeline of concerning episodes, examples of what happened before and after, any witnesses' observations, and information on sleep, medicines, health conditions, and substance exposure. Questions might include: Which symptoms require differential evaluation? Is this score reliable for this version of the questionnaire? What other conditions could account for the episodes? Would a structured dissociation interview be useful? What signs should prompt medical attention? The goal is to understand experiences and support functioning, not simply to obtain a named disorder.
Can DES-II track treatment progress?
Repeating a questionnaire may document changes in reported experiences, but the meaning of a score change depends on test stability, natural fluctuation, how the items are interpreted, and whether a change corresponds with meaningful daily functioning. A five-point decrease is not automatically a clinically important recovery signal, nor is a five-point increase proof of treatment failure. DES-II was designed primarily to assess self-reported dissociative phenomena, and research on outcome-measurement properties remains limited. A clinician should monitor distress, functioning, safety, comorbid conditions, and relevant symptom targets rather than relying on one repeated total. A DES-II result does not choose psychotherapy, prescribe medication, or determine prognosis.
Online DES-II tests and privacy
Many sites market a 'dissociation test,' sometimes adapting questionnaire wording, substituting fewer prompts, altering response scales, or displaying unexplained diagnostic labels. A trustworthy educational resource should state which version is used, how the 28 items are scored, whether the responses are complete, whether the instrument has been validated for the user's age and language, and what the result can reasonably support. It should explain data collection and storage, particularly because responses may involve sensitive mental health information. This article does not reproduce the full questionnaire prompts or administer a clinical screen; it gives information about the measure and its responsible use.
Completing the DES-II more often in response to worry is unlikely to clarify a clinical question by itself. If episodes are distressing, documenting concrete experiences and discussing them with a qualified clinician is more informative than repeatedly chasing a numerical cutoff. A change in a score should always be understood in context, with realistic expectations about measurement error and the distinction between symptoms and diagnoses.
Frequently asked questions about DES-II
Is DES-II a diagnostic test for dissociative identity disorder?
No. The DES-II is a standardized self-report assessment of dissociative experiences. Its result may suggest that a clinician should ask additional questions, but no total score confirms DID. Diagnostic criteria, clinical interviewing, longitudinal history, distress and impairment, and appropriate differentials must all be evaluated. Historical validation researchers emphasized screening, not diagnosis. Carlson et al., 1993.
What is a normal DES-II score?
There is no universal cutoff separating normal people from people with a disorder. Community and clinical samples differ, and an individual can report benign absorption, clinically relevant symptoms, or both. Clinical interpretation requires attention to symptom content, frequency, impairment, setting, and alternative explanations. The 2018 transdiagnostic meta-analysis supports caution about universal numbers.
Is a DES-II score of 30 high?
Thirty is commonly cited as a historical elevated screening cutoff for possible DID, but its meaning depends on the population and reference diagnosis. A positive screen can occur without DID; in the 1993 multicenter study, the prevalence-adjusted estimate of positive predictive value was approximately 17%. An elevated score may justify discussion with a qualified clinician; it never supplies diagnostic proof. Original 1993 research.
Can a score of 20 indicate dissociation?
It means the average of the 28 selected frequency responses is 20, not that the individual has a particular disorder. Lower screening thresholds such as 15–20 have been investigated in specific psychiatric settings for identifying people who may benefit from assessment. Actual symptoms, distress, and functioning matter more than assigning a fixed label to the number. Steinberg et al., 1991.
Can someone have DID with a DES-II score below 30?
Yes, screening instruments can produce false negatives at any proposed cutoff, especially as the threshold increases. The diagnosis is determined clinically, so a concerning presentation should be assessed even when the total does not exceed a historical research threshold. The DES-II score alone cannot confirm or exclude DID. Screening study.
Does a high score prove childhood trauma or repressed memories?
No. The DES-II asks how frequently certain experiences are reported. It cannot verify an autobiographical event, prove a specific etiological explanation, or validate the accuracy of a recollection formed during therapy. Trauma may be clinically relevant, but its presence and details are separate questions from questionnaire scoring.
Is DES-T the same as DES-II?
No. The full DES-II uses 28 items and the mean scoring rule. DES-T is an eight-item subset studied using specific taxometric models. Their intended interpretation and numerical output should be clearly identified, and neither result automatically produces a clinical diagnosis. Waller and Ross, 1997.
What is the difference between DES-II and SCID-D?
The DES-II is a questionnaire that describes self-reported frequency. SCID-D is a clinician-administered structured interview assessing dissociative symptoms in a diagnostic context. A 2021 meta-analysis supports diagnostic differentiation by the SCID-D interviews in the samples studied. Interview-based assessment still considers alternative clinical and medical explanations.
Can anxiety or panic raise a DES-II score?
Depersonalization and derealization can occur in anxiety or panic, and dissociative experiences may be reported with several other conditions. The DES-II does not identify the cause or separate the possible conditions on its own. A clinician needs to assess the episode, context, associated symptoms, and chronology. Lyssenko et al., 2018.
Is the DES-II scientifically validated?
It has a substantial history of reliability, validity, and screening studies and performed comparatively well as a measure of trait dissociation in a 2025 systematic review. That review also found substantial gaps in content validity, reliability, and methodological rigor across the instrument literature. Scientific validation for one measurement purpose does not establish accuracy for every population, language, or diagnosis. COSMIN systematic review.
Can teens take the same DES-II test?
Children and adolescents require developmental context and age-appropriate assessment. The Adolescent Dissociative Experiences Scale (A-DES) is separately studied, and its evidence should not be collapsed into the adult DES-II. Symptoms in young people also need examination by appropriately trained professionals. Review of dissociation measures.
Should I repeat a dissociation quiz until the result changes?
Repeatedly taking an online quiz does not make it a diagnostic process. If symptoms are concerning, note examples, context, and functional consequences, then discuss them with a qualified health professional. For tracking clinical progress, questionnaires are interpreted with other measurements and treatment goals, and a changing score alone is not a reliable prognosis.
How to interpret the result responsibly
DES-II is useful because it turns hard-to-describe experiences into a consistent set of questions. The score summarizes the respondent's average estimated frequency, with a higher total meaning a higher average endorsement. Its best use is to support communication and assessment. The practical conclusions follow from three separate facts: ordinary experiences can contribute to the scale; some important clinical symptoms occur below a high screening cutoff; and an elevated score does not identify the cause or diagnosis. A person deserves individualized assessment grounded in symptoms, history, safety, and evidence. Foundational validation, 1993 screening study, and 2025 measurement review.
Related Articles
References
Bernstein, E. M., & Putnam, F. W. (1986). Development, reliability, and validity of a dissociation scale. Journal of Nervous and Mental Disease, 174(12), 727–735. DOI: 10.1097/00005053-198612000-00004. PubMed.
Carlson, E. B., Putnam, F. W., Ross, C. A., Torem, M., Coons, P., Dill, D. L., Loewenstein, R. J., & Braun, B. G. (1993). Validity of the Dissociative Experiences Scale in screening for multiple personality disorder: A multicenter study. American Journal of Psychiatry, 150(7), 1030–1036. DOI: 10.1176/ajp.150.7.1030. PubMed.
Garofalo, C., Severi, I., Bruno, G., Delvecchio, E., Schimmenti, A., & Mazzeschi, C. (2026). The conceptualization and assessment of dissociation: An umbrella review of synthesis studies. Clinical Psychology Review, 124, 102702. DOI: 10.1016/j.cpr.2026.102702. PubMed.
Lyssenko, L., Schmahl, C., Bockhacker, L., Vonderlin, R., Bohus, M., & Kleindienst, N. (2018). Dissociation in psychiatric disorders: A meta-analysis of studies using the Dissociative Experiences Scale. American Journal of Psychiatry, 175(1), 37–46. DOI: 10.1176/appi.ajp.2017.17010025. PubMed.
Mychailyszyn, M. P., Brand, B. L., Webermann, A. R., Şar, V., & Draijer, N. (2021). Differentiating dissociative from non-dissociative disorders: A meta-analysis of the Structured Clinical Interview for DSM Dissociative Disorders (SCID-D). Journal of Trauma & Dissociation, 22(1), 19–34. DOI: 10.1080/15299732.2020.1760169. PubMed.
Steinberg, M., Rounsaville, B., & Cicchetti, D. (1991). Detection of dissociative disorders in psychiatric patients by a screening instrument and a structured diagnostic interview. American Journal of Psychiatry, 148(8), 1050–1054. DOI: 10.1176/ajp.148.8.1050. PubMed.
Wainipitapong, S., Millman, L. S. M., Huang, X., Wieder, L., Terhune, D. B., & Pick, S. (2025). Assessing dissociation: A systematic review and evaluation of existing measures. Journal of Psychiatric Research, 181, 91–98. DOI: 10.1016/j.jpsychires.2024.11.040. PubMed.
Waller, N. G., & Ross, C. A. (1997). The prevalence and biometric structure of pathological dissociation in the general population: Taxometric and behavior genetic findings. Journal of Abnormal Psychology, 106(4), 499–510. DOI: 10.1037/0021-843X.106.4.499. PubMed.
World Health Organization. (2024). Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders. WHO official publication.